Treffer: Quantifying post-treatment vascular remodeling in brain aneurysms using WEKA-based machine learning: a pilot study.

Title:
Quantifying post-treatment vascular remodeling in brain aneurysms using WEKA-based machine learning: a pilot study.
Source:
Frontiers in Neurology; 2025, p1-10, 10p
Database:
Complementary Index

Weitere Informationen

Introduction: To evaluate the feasibility of a WEKA-based machine learning pipeline for detecting post-treatment hemodynamic remodeling by comparing pre- and postoperative cerebral angiographic images in patients with middle cerebral artery aneurysms. Methods: This retrospective, single-center study analyzed 60 patients (51 women, 9 men; mean age, 58.2 ± 10.2 years) with unruptured middle cerebral artery aneurysms treated between January 2019 and June 2024. Thirty patients underwent microsurgical clipping, and 29 underwent endovascular intervention. A WEKA-based Random Forest classifier was trained on 15 manually annotated pre- and postoperative digital subtraction angiography (DSA) image pairs and then applied to the remaining dataset. Custom Python-based post-processing was used to denoise and refine the segmented images. Vascular surface area changes were assessed by comparing pixel counts before and after treatment. Statistical analysis included paired and unpaired t-tests, Mann-Whitney U tests, and effect size estimation. Results: Among 51 analyzable image pairs, 75% showed increased vascular pixel counts postoperatively, particularly in the endovascular group (segmented pixels: p = 0.034; refined pixels: p = 0.017). No statistically significant differences were observed in the neurosurgical group. Between-group comparisons of postoperative images did not reach significance. Conclusion: The WEKA pipeline enabled quantification of vascular remodeling but remained limited by manual preprocessing and lack of external validation. Machine learning–guided segmentation of angiographic images can detect treatment-induced vascular changes, particularly following endovascular therapy. This method demonstrates promise for future development of automated imaging biomarkers to support outcome monitoring and clinical decision-making in neurovascular care. [ABSTRACT FROM AUTHOR]

Copyright of Frontiers in Neurology is the property of Frontiers Media S.A. and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)